Despite RT-PCR confirmed COVID-19, specific antibodies to SARS-CoV-2 spike are
undetectable in serum in approximately 10% of convalescent patients after mild disease …

Continuously emerging variants of concern (VOCs) sustain the SARS-CoV-2 pandemic. The
SARS-CoV-2 Omicron/B. 1.1. 529 VOC harbours multiple mutations in the spike protein …

To understand how a protective immune response against SARS-CoV-2 develops over time,
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …

The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients
with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine …

A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill
or die, whereas others have only a mild disease course or are asymptomatic. Here, we …

The inability of patients with CVID to mount specific antibody responses to pathogens has
raised concerns on the risk and severity of SARS-CoV-2 infection, but there might be a role …

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+
and CD4+ T cells of broad specificity | Journal of Experimental Medicine | Rockefeller …

Cross-reactive immune responses to SARS-CoV-2 have been observed in pre-pandemic
cohorts and proposed to contribute to host protection. Here we assess 52 COVID-19 …

Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are
extensively documented, but these are less well studied in the (upper) respiratory tract …

Despite the growing knowledge of T cell responses in COVID-19 patients, there is a lack of
detailed characterizations for T cell-antigen interactions and T cell functions. Here, with a …